Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, MO.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
J Immunol. 2024 Apr 1;212(7):1075-1080. doi: 10.4049/jimmunol.2300336.
B cell trafficking involves the coordinated activity of multiple adhesive and cytokine-receptor interactions, and the players in this process are not fully understood. In this study, we identified the tetraspanin CD53 as a critical regulator of both normal and malignant B cell trafficking. CXCL12 is a key chemokine in B cell homing to the bone marrow and secondary lymphoid organs, and both normal and malignant B cells from Cd53-/- mice have reduced migration toward CXCL12 in vitro, as well as impaired marrow homing in vivo. Using proximity ligation studies, we identified the CXCL12 receptor, CXCR4, as a novel, to our knowledge, CD53 binding partner. This interaction promotes receptor function, because Cd53-/- B cells display reduced signaling and internalization of CXCR4 in response to CXCL12. Together, our data suggest that CD53 interacts with CXCR4 on both normal and malignant B cells to promote CXCL12 signaling, receptor internalization, and marrow homing.
B 细胞迁移涉及多种黏附分子和细胞因子受体相互作用的协调活动,而这一过程中的参与者尚未完全了解。在这项研究中,我们鉴定出四跨膜蛋白 CD53 是正常和恶性 B 细胞迁移的关键调节剂。趋化因子 CXCL12 是 B 细胞归巢骨髓和次级淋巴器官的关键趋化因子,来自 Cd53-/- 小鼠的正常和恶性 B 细胞在体外向 CXCL12 的迁移能力降低,体内归巢骨髓的能力受损。通过邻近连接研究,我们确定了趋化因子受体 CXCR4 是一种新的、据我们所知的 CD53 结合伴侣。这种相互作用促进了受体功能,因为 Cd53-/- B 细胞在响应 CXCL12 时显示出 CXCR4 信号转导和内化减少。总之,我们的数据表明 CD53 与正常和恶性 B 细胞上的 CXCR4 相互作用,以促进 CXCL12 信号转导、受体内化和归巢骨髓。